Results of the Lynn sage second-opinion program for local therapy in patients with breast carcinoma - Changes in management and determinants of where care is delivered

被引:38
作者
Clauson, J
Hsieh, YC
Acharya, S
Rademaker, AW
Morrow, M
机构
[1] Northwestern Univ, Lynn Sage Breast Program, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA
关键词
breast carcinoma; initial consultation; surgery; second opinion;
D O I
10.1002/cncr.10318
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The treatment options of breast conservation therapy (BCT) and immediate reconstruction for patients with carcinoma of the breast have not been adopted widely. The objectives of this study were to determine how often a second opinion on the local therapy of breast carcinoma changed patient management and to identify factors predictive of remaining at the second-opinion site for therapy. METHODS. Two hundred thirty-one patients with intraductal carcinoma or Stage I and II breast carcinoma were reviewed retrospectively. At the time of the second opinion, patients completed a questionnaire regarding their initial surgical opinion and the reason for seeking consultation. RESULTS. Only 46% of patients had a complete discussion of treatment options prior to the second opinion. The second opinion changed management in 54 patients (20.3%). The most common finding was eligibility for BCT in patients who were offered only mastectomy. Definitive local therapy occurred at the second-opinion site in 65.8% of patients. The only predictors of remaining at the second-opinion site were insurance type (P = 0.008) and the patient's perception that options were not discussed at the initial opinion (P < 0.001). CONCLUSIONS. Second opinions provide useful information to patients and may change the management of their disease. They result in significant patient capture for an institution. (C) 2002 American Cancer Society.
引用
收藏
页码:889 / 894
页数:6
相关论文
共 25 条
[1]  
Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO
[2]  
2-K
[3]  
Chu A, 1992, Empl Benefits J, V17, P35
[4]   THE EFFECT OF A SECOND OPINION PROGRAM ON HYSTERECTOMY PERFORMANCE [J].
FINKEL, ML ;
FINKEL, DJ .
MEDICAL CARE, 1990, 28 (09) :776-783
[5]   BREAST-CONSERVING SURGERY FOR BREAST-CANCER - PATTERNS OF CARE IN A GEOGRAPHIC REGION AND ESTIMATION OF POTENTIAL APPLICABILITY [J].
FOSTER, RS ;
FARWELL, ME ;
COSTANZA, MC .
ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (03) :275-280
[6]   RESULTS OF A 2ND-OPINION PROGRAM FOR CORONARY-ARTERY BYPASS GRAFT-SURGERY [J].
GRABOYS, TB ;
HEADLEY, A ;
LOWN, B ;
LAMPERT, S ;
BLATT, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (12) :1611-1614
[7]   Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey [J].
Hewitt, M ;
Breen, N ;
Devesa, S .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17) :1480-1486
[8]   Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment [J].
Kotwall, CA ;
Maxwell, JG ;
Covington, DL ;
Churchill, P ;
Smith, SE ;
Covan, EK .
ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (02) :169-175
[9]   IMPACT OF A MANDATORY 2ND-OPINION PROGRAM ON MEDICAID SURGERY RATES [J].
MARTIN, SG ;
SHWARTZ, M ;
WHALEN, BJ ;
DARPA, D ;
LJUNG, GM ;
THORNE, JH ;
MCKUSICK, AE .
MEDICAL CARE, 1982, 20 (01) :21-45
[10]  
MCCARTHY EG, 1981, LANCET, V1, P1352